209 related articles for article (PubMed ID: 19580432)
21. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.
Foroni L; Gerrard G; Nna E; Khorashad JS; Stevens D; Swale B; Milojkovic D; Reid A; Goldman J; Marin D
Am J Hematol; 2009 Aug; 84(8):517-22. PubMed ID: 19544476
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in biological and therapeutic aspects of myeloproliferative disorders.
Mancini M; Diverio D; Alimena G; Mandelli F
Curr Opin Hematol; 1994 Jul; 1(4):261-7. PubMed ID: 9371292
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
Bench AJ; Erber WN; Scott MA
Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
[TBL] [Abstract][Full Text] [Related]
24. [An unusual chronic myeloproliferation].
Kolesková E; Háber J; Klener P
Vnitr Lek; 1989 May; 35(5):489-92. PubMed ID: 2763484
[TBL] [Abstract][Full Text] [Related]
25. [Chronic myeloproliferative syndromes].
de Ozalla CB; García Suárez J
Rev Clin Esp; 1999 Apr; 199 Suppl 1():28-36. PubMed ID: 10422448
[No Abstract] [Full Text] [Related]
26. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
27. Chronic myeloproliferative disorders--introduction.
Skoda R; Prchal JT
Semin Hematol; 2005 Oct; 42(4):181-3. PubMed ID: 16210031
[No Abstract] [Full Text] [Related]
28. Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia.
Zhao Y; Wu G; Wu K; Liu L; Cao W; Yu X; Luo Y; Shi J; Tan Y; Huang H
Leuk Res; 2009 Jul; 33(7):e85-7. PubMed ID: 19203793
[No Abstract] [Full Text] [Related]
29. Chromosome abnormalities in the myeloproliferative disorders.
Dewald GW; Wright PI
Semin Oncol; 1995 Aug; 22(4):341-54. PubMed ID: 7638632
[No Abstract] [Full Text] [Related]
30. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of quantification of major bcr-abl mRNA between TMA (transcription mediated amplification) method and real-time quantitative PCR].
Yagasaki F; Niwa T; Abe A; Ishikawa M; Kato C; Ogura K; Sasaki H; Kyo T; Jinnai I; Bessyo M; Miyamura K
Rinsho Ketsueki; 2009 Jun; 50(6):481-7. PubMed ID: 19571508
[TBL] [Abstract][Full Text] [Related]
32. Myeloproliferative syndromes: diagnosis and therapeutic options.
Hellmann A
Pol Arch Med Wewn; 2008 Dec; 118(12):756-60. PubMed ID: 19202955
[TBL] [Abstract][Full Text] [Related]
33. BCR-ABL1-negative chronic myeloid neoplasms: an update on management techniques.
Vannucchi AM; Pieri L; Susini MC; Guglielmelli P
Future Oncol; 2012 May; 8(5):575-93. PubMed ID: 22646772
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm.
Chen Z; Wang W; Verstovsek S; Cortes JE; Medeiros LJ; Hu S
Int J Lab Hematol; 2015 Dec; 37(6):e150-2. PubMed ID: 26086872
[No Abstract] [Full Text] [Related]
35. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
Kim HY; Park S; Kim SH; Kim HJ
Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
[No Abstract] [Full Text] [Related]
36. [The quality practice of molecular-genetic testing in the era of molecular target therapy in chronic myelogenous leukemia].
Miyachi H; Matsushita H; Masukawa A; Asai S
Rinsho Byori; 2012 Oct; 60(10):982-7. PubMed ID: 23323464
[TBL] [Abstract][Full Text] [Related]
37. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
Diamond JM; de Almeida AM; Belo HJ; da Costa MP; Cabeçadas JM; Abecasis MM
Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446
[No Abstract] [Full Text] [Related]
38. Confirmation of a novel recurrent association: BCR-ABL t(9;22) and t(19;21).
Struski S; Hélias C; Gervais C; Leymarie V; Audhuy B; Moskovtchenko P; Lutz P; Gaub MP; Lessard M
Cancer Genet Cytogenet; 2007 Dec; 179(2):127-31. PubMed ID: 18036399
[TBL] [Abstract][Full Text] [Related]
39. Monitoring of minimal residual disease in leukemia, advantages and pitfalls.
Cazzaniga G; Gaipa G; Rossi V; Biondi A
Ann Med; 2006; 38(7):512-21. PubMed ID: 17101542
[TBL] [Abstract][Full Text] [Related]
40. [The molecular diagnosis of cancer].
Barrera Saldaña H; Martínez Garza S; Ortiz López R
Rev Invest Clin; 2003; 55(2):128-37. PubMed ID: 12827915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]